DNA Precious Metals Inc. Announces Initial Coverage by Goldman Small Cap Research

MONTREAL, March 6, 2014 /PRNewswire/ --

DNA Precious Metals Inc. ("DNA" or "the Company") (OTCQB: DNAP), a near term gold and silver producer, today announced that Goldman Small Cap Research, a stock market research firm, based out of Baltimore, Maryland and focused on the small cap and microcap sectors, has initiated research coverage of DNA Precious Metals Inc.

DNA Precious Metals Inc. is in the final stages of securing production financing for its Montauban Tailings Mine, adjacent to the Montauban lead zinc mine, which was a long term producer of lead zinc gold and silver for most of the 20^th century.  The Company has already completed construction of all access roads to and from the milling facility located on the Montauban Mine Property.  In addition, the company has also completed all hydro power source infrastructural work spanning 1.3 kilometres to the newly erected 16,000 sq/ft steel structure building.

DNA Precious Metals Inc. has established first-mover advantage as a company focused on putting tailings mines into production and whose expertise in tailings exploitation has positioned it as a national innovator.

In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.

"Silver prices should rise due to both investing and manufacturing demand increases.  Finally, there should be consideration that inflation could be a serious issue longer term given the extent and time duration of the Fed stimulus, which could amplify if the economy enters a true bust out growth cycle and rising prices.  Thus, an investment in DNA Precious Metals is an undervalued opportunity to capitalize on another potential gold and silver boom."

About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on their website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download their research, view their disclosures, or for more information, visit http://www.goldmanresearch.com.

About DNA Precious Metals, Inc.

DNA Precious Metals, Inc. is focused on near term production of the Montauban tailings mine in the Province of Quebec, Canada with an aggressive search for economic production assets. The company trades on the OTCQB market in the United States under the stock symbol DNAP. For more information, please go to http://www.DNAPreciousMetals.com.

On behalf of the Board

Tony Giuliano, CEO

Forward Looking Disclaimer

This release contains forward-looking statements that involve risks and uncertainties.  Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements.  The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.

CONTACT INFORMATION
Tony Giuliano
+1-514-852-2111
DNA Precious Metals Inc.
[email protected]
Twitter : http://www.twitter.com/dnametals
Facebook :http://www.facebook.com/dnametals

SOURCE DNA Precious Metals Inc.